Ganglioside mimicry as a cause of Guillain-Barre syndrome
Ganglioside mimicry as a cause of Guillain-Barre syndrome
复制标题
DOI:
10.1097/01.wco.0000174604.42272.2d
复制
发表时间:
2005-10-01
影响因子:
4.8
通讯作者:
Odaka, M
中科院分区:
文献类型:
--
作者:
Yuki, N;Odaka, M
Purpose of review Campylobacter jejuni is the most frequent agent of antecedent infection in an axonal variant of Guillain-Barre syndrome, acute motor axonal neuropathy, and anti-GM1 or anti-GD1 a lgG antibody is also associated with acute motor axonal neuropathy. Molecular mimicry has been found between human GM1 ganglioside and the lipo-oligosaccharicle of C. jejuni isolated from an acute motor axonal neuropathy patient. Progress has been made in Guillain-Barre syndrome research, especially on acute motor axonal neuropathy subsequent to C. jejuni enteritis.Recent findings Sensitization of rabbits with C. jejuni lipo-oligosaccharide, as well as GM1, induced the production of anti-GM1 lgG antibody, and the subsequent development of acute flaccid paralysis. Pathological changes in rabbit peripheral nerves were identical to those seen in human acute motor axonal neuropathy. These findings provide conclusive evidence that molecular mimicry is a cause of human autoimmune disease. Ganglioside-like lipo-oligosaccharicle is synthesized by sialyltransferase Cst-II, N-acetylgalactosaminyl-transferase CgtA, and galactosyltransferase CgtB. There is a strong association between the simultaneous presence of these genes and Guillain - Barre syndrome-associated C. jejuni strains. Knockout mutants of C. jejuni genes involved in lipo-oligosaccharicle sialylation had reduced reactivity with anti-GM1 sera from Guillain-Barre syndrome patients, and did not induce an anti-GD1 a IgG antibody response in mice. Lipo-oligosaccharide biosynthesis genes appear to be essential for the induction of anti-GM1 or anti-GD1 a IgG antibody and the subsequent development of acute motor axonal neuropathy.Summary The concept that carbohydrate mimicry causes autoimmune disease provides a clue to the resolution of the pathogenesis of other immune-mediated diseases.